RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Cash and cash equivalents

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Dec 31, 20242,063+55.65%
Dec 31, 20231,326-23.26%
Dec 31, 20221,727-3.56%
Dec 31, 20211,791-33.33%
Dec 31, 20202,686+27.56%
Dec 31, 20192,106-9.56%
Dec 31, 20182,329-42.18%
Dec 31, 20174,027-11.55%
Dec 31, 20164,553+249.91%
Dec 31, 20151,301-75.99%
Dec 31, 20145,418

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)